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Helicobacter pylori 26695, a highly pathogenic bacterium, is a human gastric epithelia colonizer, correlated with the 
development of duodenal and gastric ulcers, and gastric cancer worldwide. Its genome has been previously sequenced 
and annotated, and two genome-scale metabolic models have been developed; however, since their publication, vast 
amounts of data and new methodologies have been developed. In order to maintain accurate and relevant the 
information on this bacterium, and to generate new information and new approaches for its analysis, the assignment of 
new functions to H. pylori 26695’s genes was performed and a new genome-scale metabolic model was reconstructed.  
This work originated the iTR383 metabolic model, a compartmentalized model containing 383 genes and composed by 
640 different reactions and 412 metabolites.  
Gene essentiality analysis and growth simulations were performed using experimental data and nutrient uptake rates to 
assess the predictive capabilities of the model. Metabolite and flux distribution in the central carbon metabolism 
pathway using different carbon sources were analysed, as well as pathways for non-essential amino acids 
biosynthesis, the nitric oxide influx effect, and electron transport and respiratory chain.  
This model accurately predicts H. pylori’s phenotypic response to different carbon sources and is in agreement with 
experimental results obtained in minimal and complex media. We believe that this work represents a significant 
advance in understanding H. pylori 26695’s metabolism and will provide relevant biological information to the scientific 
community working on new approaches for enhanced treatments. 
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We study how the severity of a mutation affects pleiotropy in genome-scale metabolic networks. We measure 
pleiotropy as the number of biomass components whose maximal production is reduced by the mutation. For each 
biomass component, we added a new exchange reaction and maximized the corresponding secretion. For each gene, 
we simulated mutations of different severity by restricting the flux through all reactions catalyzed by the gene to a fixed 
fraction of the wildtype flux, which we reduced in 10%-steps. We then examined how the maximal production of each 
biomass component differs between mutant and wildtype. For a genome-scale model of E. coli metabolism in minimal 
medium, we found that mutations for 16% of genes whose knockout resulted in a fitness reduction showed a linear 
relationship between flux reduction and biomass production. A further 4% showed a steeper decline of biomass 
production at more severe mutational strengths. The majority of genes show either zero or constant pleiotropy 
independent of mutation severity. However, about 21% of essential genes show a stepwise increase of pleiotropy with 
increasing mutation severity. A large fraction of pleiotropy is associated with energy production: when we make ATP 
freely available, 26% of previously pleiotropic genes no longer affected the production of biomass components, with a 
further 8% showing reduced pleiotropy. 
